BOUNDLESS: AN ACTIVE-CONTROLLED, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY TRIAL OF CONTINUOUS SUBCUTANEOUS INFUSION OF LEVODOPA/CARBIDOPA WITH ND0612 IN PATIENTS WITH PARKINSON'S DISEASE

被引：0
|
作者：
Rascol, O. [1 ,2 ]
Poewe, W. [3 ]
Stocchi, F. [4 ]
Yardeni, T. [5 ]
Barak, S. Leibman [5 ]
Adar, L. [5 ]
Rosenfeld, O. [5 ]
Olanow, C. W. [6 ]
机构：
[1] Univ Toulouse, CHU Toulouse, Toulouse, France
[2] INSERM, Toulouse, France
[3] Med Univ Innsbruck, Innsbruck, Austria
[4] IRCCS San Raffaele Pisana, Inst Neurol, Rome, Italy
[5] NeuroDerm Ltd, Rehovot, Israel
[6] Clintrex, Sarasota, FL USA
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 186
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [41] Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
    Baumgartner, Rudolf A.
    Hanania, Nicola A.
    Calhoun, William J.
    Sahn, Steven A.
    Sciarappa, Kenneth
    Hanrahan, John P.
    CLINICAL THERAPEUTICS, 2007, 29 (02) : 261 - 278
  • [42] Pharmacokinetic profile of ND0612L (levodopa/carbidopa for subcutaneous infusion) in patients with moderate to severe Parkinson's disease
    Giladi, N.
    Caraco, Y.
    Gurevich, T.
    Djaldetti, R.
    Cohen, Y.
    Yacobi-Zeevi, O.
    Oren, S.
    MOVEMENT DISORDERS, 2015, 30 : S87 - S88
  • [43] Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial
    Tolosa, Eduardo
    Hernandez, Basilio
    Linazasoro, Gurutz
    Jose Lopez-Lozano, Juan
    Mir, Pablo
    Marey, Jose
    Kulisevsky, Jaime
    JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (04) : 357 - 366
  • [44] Pharmacokinetic profile of ND0612 (levodopa/carbidopa for subcutaneous infusion) in Parkinson's disease (PD) patients with motor fluctuations: results of a phase IIa dose finding study
    Giladi, N.
    Caraco, Y.
    Gurevich, T.
    Djaldetti, R.
    Cohen, Y.
    Yacobi-Zeevi, O.
    Oren, S.
    Kieburtz, K.
    Olanow, C. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 66 - 66
  • [45] Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
    Eduardo Tolosa
    Basilio Hernández
    Gurutz Linazasoro
    Juan José López-Lozano
    Pablo Mir
    José Marey
    Jaime Kulisevsky
    Journal of Neural Transmission, 2014, 121 : 357 - 366
  • [46] Randomized, phase 3, double-blind, double-dummy study of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Functional and quality-of-life outcomes
    Kieburtz, K.
    Antonini, A.
    Olanow, C. W.
    Fernandez, H. H.
    Espay, A. J.
    Standaert, D. G.
    Hass, S.
    Widnell, K. L.
    Robieson, W. Z.
    Pritchett, Y.
    Chatamra, K.
    Benesh, J.
    MOVEMENT DISORDERS, 2012, 27 : S124 - S124
  • [47] Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study
    Sarva, H.
    Tagliati, M.
    Poewe, W.
    Stocchi, F.
    Rascol, O.
    Yardeni, T.
    Lopes, N.
    Pereira, J.
    Espay, A.
    MOVEMENT DISORDERS, 2024, 39 : S298 - S298
  • [48] Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study
    Ellenbogen, Aaron L.
    Poewe, Werner
    Espay, Alberto J.
    Simuni, Tanya
    Gurevich, Tanya
    Yardeni, Tami
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Stocchi, Fabrizio
    BeyoND Study Grp
    PARKINSONISM & RELATED DISORDERS, 2025, 132
  • [49] A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial
    Adigweme, Ikechukwu
    Yisa, Mohammed
    Ooko, Michael
    Akpalu, Edem
    Bruce, Andrew
    Donkor, Simon
    Jarju, Lamin B.
    Danso, Baba
    Mendy, Anthony
    Jeffries, David
    Segonds-Pichon, Anne
    Njie, Abdoulie
    Crooke, Stephen
    El-Badry, Elina
    Johnstone, Hilary
    Royals, Michael
    Goodson, James L.
    Prausnitz, Mark R.
    McAllister, Devin, V
    Rota, Paul A.
    Henry, Sebastien
    Clarke, Ed
    LANCET, 2024, 403 (110439): : 1879 - 1892
  • [50] Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
    Dignass, Axel
    Stoynov, Simeon
    Dorofeyev, Andrey E.
    Grigorieva, Galina A.
    Tormova, Eva
    Altorjay, Istvan
    Tuculanu, Daniel
    Bunganic, Ivan
    Pokrotnieks, Juris
    Kupcinskas, Limas
    Dilger, Karin
    Greinwald, Roland
    Mueller, Ralph
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (09): : 970 - 980
12345